Physician

Abdul Majid, M.D.

According to 2025 Medicare claims, Abdul Majid, M.D. (NPI: 1831287416) practices internal medicine in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is STATE OF NEW JERSEY OMB CENTRALIZED PAYROLL (NPI: 1467552240) and primary practice location at 08628-3425.

Majid's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 18 traditional Medicare patients, billed 33 HCPCS/CPT codes, and received $1,894 in Medicare payments. 2024 Part D data shows 183 prescription claims across 29 beneficiaries totaling $5,435 in drug costs, led by Telmisartan (Telmisartan). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $7,343 to $1,894. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $14,992 to $5,435. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	61	142	$7,343
2016	36	114	$5,047
2017	25	64	$2,564
2018	40	143	$5,305
2019	37	126	$5,755
2020	38	174	$7,684
2021	29	201	$9,048
2022	28	111	$3,716
2023	18	33	$1,894
2024	N/R	N/R	N/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	471	$14,992
2016	41	412	$129,979
2017	31	199	$90,627
2018	35	185	$6,635
2019	23	166	$9,591
2020	32	206	$5,332
2021	28	189	$3,569
2022	30	165	$34,494
2023	26	238	$11,265
2024	29	183	$5,435

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Telmisartan	Telmisartan	18	504	$605
Levothyroxine Sodium	Levothyroxine Sodium	20	524	$423
Pantoprazole Sodium	Pantoprazole Sodium	12	360	$287
Metformin Hcl	Metformin Hcl	23	577	$279
Rosuvastatin Calcium	Rosuvastatin Calcium	12	364	$206

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Abdul Majid, M.D.?

Tedicare shows public-source Medicare data for Abdul Majid, M.D. (NPI 1831287416), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Majid, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul Majid, M.D.?

Abdul Majid, M.D. is linked to STATE OF NEW JERSEY OMB CENTRALIZED PAYROLL (billing NPI 1467552240) in the available physician profile data.

Does Abdul Majid, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.